Thomas Moulinet

[La Revue de Médecine Interne @RevMedInterne]

📝Mise au point
Tendinopathies sous fluoroquinolones : quels patients sont à risque ? Comment les reconnaître et les prendre en charge ?
👉 Les réponses dans cet article : https://t.co/Z4RheiWIfm

[EULAR @eular_org]

📢 NEWS ALERT!

EULAR has updated and unified recommendations for the management of polymyalgia rheumatica and large vessel vasculitis, bringing together the latest evidence to support improved diagnosis, treatment, and patient outcomes.

More here 👉 https://t.co/RP1mhqu9Uk

[NatRevRheumatol @NatRevRheumatol]

New content online: Dapirolizumab pegol improves SLE disease activity in phase III trial https://t.co/eksDGRVQ1Z

[Rohit Aggarwal @docrota]

🧠 Living with myositis?
You can help advance research-right from your phone, anywhere in the world
Join My PACER Registry, a global myositis study by the University of Pittsburgh.
🔗 https://t.co/RFCn9FQ1Mh
#Myositis #Dermatomyositis #Polymyositis #MyositisResearch #RareDisease

[Trends in Immunology @TrendsImmuno]

Metabolic regulatory nodes of the inflammasome and inflammatory cell death https://t.co/tf7RPPSD6k #immunology

[Thomas Moulinet @MoulinetThomas]

Happy to share our latest work on longitudinal trajectories of ILD in antisynthetase syndrome, now available open access in @ArchBronconeumo :
https://t.co/LqH06gAU6N
Congratulation to Maxime Billotte and Paul Decker, and many thanks to all collaborators involved!

[NEJM @NEJM]

Paul Bastard, MD, PhD, and Jean-Laurent Casanova, MD, PhD, describe the scientific foundations of a study implicating autoantibodies against interleukin-10 in persons with inflammatory bowel disease.

Read the editorial “Autoantibodies against Cytokines — From Infection to Inflammation”: https://t.co/Ja8nORGjYr

[Cell @CellCellPress]

Now online! Long-term reversal of Duchenne muscular dystrophy via circular arRNA-guided exon skipping in monkeys and humans https://t.co/SbwWwAsGlk

[Jerome HADJADJ @HadjadjJerome]

Interleukin-10 Autoantibodies and HLA-DRB1*01:03 in Inflammatory Bowel Disease https://t.co/E8VDJoPKzq

[Ivan Zanoni @Lo_Zanzi]

#WeekendRead! #EveryCellIsAnImmuneCell! @Luke_Brown_91 Yipp &co show @ScienceMagazine that platelet cathelicidin drives neutrophil-platelet lung aggregates amplified by LTB4 driving lethal immunothrombi in sepsis! LTB4 blockade prevents immunopathology! https://t.co/GldxA8ZMFj

[Ming "Tommy" Tang @tangming2005]

5 papers all computational biologists should read 🧵

1. A Quick Guide to Organizing Computational Biology Projects
https://t.co/wSvnEKPa6i

[Waggoner Lab @LabWaggoner]

DLL4, GM-CSF, and TGFβ coordinate transcriptional networks that, together with the RXR–PPARγ axis, which regulate chromatin and gene expression to establish and maintain alveolar macrophage identity @jexpmed
https://t.co/elvoApBaXH 🇪🇸

[Cell @CellCellPress]

In the latest issue! Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections https://t.co/y30oKLvwj2

[NatRevRheumatol @NatRevRheumatol]

New content online: Lytic cell death turns TRIM21 into an autoantigen https://t.co/wtPcRChkKH

[Akira Yoshida @akiyosshii1]

Our article from the CLASS project received enough views to be a Top Viewed Article in Arthritis and Rheumatology @ACR_Journals Read it here https://t.co/Me93Gt0DAK #TopViewedArticle @wileyinresearch

[The Lancet Rheumatology @TheLancetRheum]

NEW RESEARCH—Efficacy and safety of enpatoran, a Toll-like receptor 7/8 inhibitor, in patients with skin manifestations of cutaneous lupus erythematosus or systemic lupus erythematosus: findings from Cohort A of a phase 2 trial https://t.co/kcBDWH0vuc #WorldLupusDay

[ACR_Journals @ACR_Journals]

MRL/lpr and TLR7 agonist-induced lupus nephritis mouse model study provides evidence the kidneys in lupus nephritis may act as sites of extramedullary hematopoiesis and contribute to disease progression through local myeloid cell expansion

Arthritis & Rheumatology
https://t.co/EIrdAvKfnr

[Casanova Lab @casanova_lab]

How I Treat: Haploinsufficiency of A20 https://t.co/vwRNAjXGu0

[Ivan Zanoni @Lo_Zanzi]

Fascinating! Sampling of living cells rather than utilization of apoptotic bodies as a way to maintain tolerance to self! @Nature @amycfanphd @MaxKrummel @RukmanThota, Serwas &co 👇👉 https://t.co/V8klNiCuCC

[‏Dr. Lina El Kibbi 🩺 د. لينا فيصل الكبي @linakibbe]

#EULAR #recommendations for the management of systemic #lupus erythematosus with kidney involvement: 2025 update

Ann Rheum Dis 85 (2026) 75−90
#lupus #SLE
https://t.co/e1FmhGC9fe